Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

Compound 4 is a promising treatment for hair loss with low toxicity.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

A new protein, mK6irs, is found in specific hair layers and may help understand hair growth and diseases.

A genetic marker linked to a type of hair loss was found in most patients studied.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Laser treatment for hair loss works equally well on different skin types, but more research is needed for very dark skin.

Lifestyle choices like stress, smoking, heavy drinking, sun exposure, and chemical hair treatments might speed up hair loss in people with androgenetic alopecia.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Microfluidics can create precise, efficient delivery systems for food and cosmetics, but scaling up is challenging.

Scientists identified a unique type of human skin stem cell that could help with tissue repair.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Glycerin in hand cream can cause allergic skin reactions.

Hair and wool strength is affected by the number and type of bonds in their protein structures, with hair having more protein aggregates than wool.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

New compounds show promise as nonsteroidal treatments for hair loss.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.